Estudio comparativo de pruebas serológicas para el diagnóstico de la Leishmaniasis visceral canina: Nota técnica. Article (PDF Available) in Revista científica. Tres pruebas serológicas (TAD, IFI y ELISA) fueron evaluadas en sueros de pacientes con Leishmaniasis cutánea Americana (LCA) en diferentes condiciones. PRUEBAS SEROLÓGICAS. INTEGRANTES: GABRIELA CAMACHO KERLY VARGAS ERICK RAMOS GALO VALVERDE FRANKLIN YUQUILEMA PRUEBA DE.

Author: Daimuro Faektilar
Country: Nicaragua
Language: English (Spanish)
Genre: Business
Published (Last): 14 September 2004
Pages: 183
PDF File Size: 14.53 Mb
ePub File Size: 3.87 Mb
ISBN: 129-3-95040-272-8
Downloads: 68768
Price: Free* [*Free Regsitration Required]
Uploader: Arashilmaran

Pillonel J, Laperche S. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

Rev Invest Clin ; 58 2: Centers for Disease Control and Prevention. A survey pruevas blood centers and deferred donors. Impact of nucleic acid amplification technology NAT in Italy in the three years following implementation Los resultados de los ensayos fueron interpretados de acuerdo con las recomendaciones del fabricante. Prevalence, incidence, zerologicas residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.

TOP Related  CSA A23.3-04 PDF

¿Cómo interpretar las pruebas serológicas para Hepatitis B? – Artículos – IntraMed

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. During one year, we evaluated 47 blood donors.

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: The window period was defined with the positive NAT and negative serological test. False-reactive microbiologic screening test results in Swedish blood donors-how big is the problem? Transfusion Jul;50 7: Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus.

Positive NAT was demonstrated only in donors with positive serology: Euro Surveill [serie en internet] [consultado abril 28]; 10 2: Positive serological testing were found for HBV in 78 0. Very low hepatitis C antibody level predict false-positive result avoid supplemental testing.

Medical history was made and provided an information brochure and self-exclusion questionnaire. Los autores declararon no tener conflicto de intereses. Preubas report Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Vox Sang ;86 1: Arch Pathol Lab Med ; 5: Transfusion ; 50 6: Los resultados de los ensayos fueron interpretados de acuerdo a las recomendaciones del fabricante.


Arch Intern Med ; 9: Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donors population from to Los resultados del ensayo se interpretaron de acuerdo con las recomendaciones del fabricante. Las determinaciones del NAT alternativo fueron: Current risks of transfusion- seroloogicas agents: Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.